{"schema_version":"secwatch.filing_event.v1","accession":"0000950170-25-083913","form_type":"8-K","ticker":"TCRT","cik":"0001107421","company_name":"Alaunos Therapeutics, Inc.","filed_at":"2025-06-10T23:59:59+00:00","discovered_at":"2026-05-14T18:02:47.537542+00:00","generated_at":"2026-05-19T15:08:44.365281+00:00","sec_items":["1.01","3.02","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.45,"calibrated_materiality_score":0.45,"confidence":"high","headline":"Alaunos Therapeutics amends warrant with Mast Hill Fund, adds $0.57 floor price","bullets":["Added floor price of $0.57 per share to exercise price adjustments in warrant issued May 19, 2025.","Removed requirement to adjust number of shares issuable upon dilutive issuance or variable price events.","Removed certain warrant holder rights in connection with fundamental transactions.","Amendment effective June 9, 2025; warrant originally issued concurrently with equity purchase agreement."],"urls":{"canonical":"https://secwatch.observer/filing/0000950170-25-083913","json":"https://secwatch.observer/filing/0000950170-25-083913.json","markdown":"https://secwatch.observer/filing/0000950170-25-083913.md","text":"https://secwatch.observer/filing/0000950170-25-083913.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1107421/000095017025083913/0000950170-25-083913-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1107421/000095017025083913/tcrt-20250609.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-19T15:08:44.365281+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}